Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03793179
What this trial is testing

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 600
Post-approval studies (Phase 4)Study completedNCT00492232
What this trial is testing

Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia

Who this might be right for
Chronic Insomnia
Takeda 135
Testing effectiveness (Phase 2)Ended earlyNCT02654639
What this trial is testing

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Georgetown University 4
Testing effectiveness (Phase 2)UnknownNCT01210053
What this trial is testing

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 30
Testing effectiveness (Phase 2)Study completedNCT05219435
What this trial is testing

Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Urothelial Cancer
Spanish Oncology Genito-Urinary Group 25
Large-scale testing (Phase 3)UnknownNCT03598348
What this trial is testing

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Huazhong University of Science and Technology 288
Not applicableEnded earlyNCT02217033
What this trial is testing

Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo

Who this might be right for
Breast Cancer
South Sound Care Foundation 16
Large-scale testing (Phase 3)Ended earlyNCT02145598
What this trial is testing

Treatment Optimization in Patients With Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dr. med. Lars-Olof Muegge 85
Early research (Phase 1)Study completedNCT00254384
What this trial is testing

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 50
Large-scale testing (Phase 3)UnknownNCT02875457
What this trial is testing

Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 100
Early research (Phase 1)Active Not RecruitingNCT03923270
What this trial is testing

Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive StageSmall-cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 25
Large-scale testing (Phase 3)Study completedNCT00756002
What this trial is testing

Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia

Who this might be right for
Sleep Initiation and Maintenance Disorders
Takeda 259
Testing effectiveness (Phase 2)Study completedNCT00040937
What this trial is testing

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 147
Post-approval studies (Phase 4)UnknownNCT00011895
What this trial is testing

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
GlaxoSmithKline 400
Testing effectiveness (Phase 2)WithdrawnNCT00408967
What this trial is testing

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

Who this might be right for
Ovarian Cancer
EMD Serono
Testing effectiveness (Phase 2)Study completedNCT01899599
What this trial is testing

PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer RecurrentFallopian Tube CancerPrimary Peritoneal Cancer
Glycotope GmbH 216
Large-scale testing (Phase 3)Study completedNCT02611830
What this trial is testing

Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Takeda 383
Large-scale testing (Phase 3)Active Not RecruitingNCT02655016
What this trial is testing

Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 733
Testing effectiveness (Phase 2)Ended earlyNCT01548573
What this trial is testing

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

Who this might be right for
Multiple Myeloma
University of Iowa 19
Testing effectiveness (Phase 2)Study completedNCT01700673
What this trial is testing

Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Next Page